trending Market Intelligence /marketintelligence/en/news-insights/trending/4vYxYrp33Q7Rxdn2hKw2Sg2 content esgSubNav
In This List

Apotheca Biosciences appoints chairman/CEO

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Apotheca Biosciences appoints chairman/CEO

Apotheca Biosciences Inc. appointed P.C. Sundareswaran as chairman and CEO, effective Jan. 1, 2019.

The Saint Petersburg, Fla.-based company said Sam Talari had resigned as CEO and director on Dec. 4. Apotheca said Talari's decision was based on personal matters and not related to any disagreement with the company.

The company's Chief Technology Officer John Verghese will act as CEO until Sundareswaran assumes the role.

In addition, Apotheca COO Deidre Fernandes was elected as a board member, effective Dec. 4.

Apotheca develops nutraceuticals, formulations, and delivery technologies for the healthcare and consumer care industry.